These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 32641447

  • 1. Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis.
    Derakhshan MH, Dean L, Jones GT, Siebert S, Gaffney K.
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32641447
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients.
    Rueda-Gotor J, Ferraz-Amaro I, Genre F, González Mazón I, Corrales A, Portilla V, Llorca J, Agudo-Bilbao M, Aurrecoechea E, Expósito R, Hernández-Hernández V, Quevedo-Abeledo JC, Rodríguez-Lozano C, Lopez-Medina C, Ladehesa-Pineda ML, Castañeda S, Vicente EF, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, Vivar MLG, Galíndez-Agirregoikoa E, Perez EM, Fernández Díaz C, Blanco R, González-Gay MÁ.
    Semin Arthritis Rheum; 2022 Dec; 57():152096. PubMed ID: 36150319
    [Abstract] [Full Text] [Related]

  • 3. The effect of extra-articular manifestations on tumor necrosis factor-α inhibitor treatment duration in patients with ankylosing spondylitis: nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry.
    Kim Y, Park S, Kim HS.
    Clin Rheumatol; 2018 Dec; 37(12):3275-3284. PubMed ID: 30251059
    [Abstract] [Full Text] [Related]

  • 4. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort.
    van Lunteren M, Sepriano A, Landewé R, Sieper J, Rudwaleit M, van der Heijde D, van Gaalen F.
    Arthritis Res Ther; 2018 Aug 03; 20(1):166. PubMed ID: 30075809
    [Abstract] [Full Text] [Related]

  • 5. The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW.
    van der Horst-Bruinsma I, van Bentum R, Verbraak FD, Rath T, Rosenbaum JT, Misterska-Skora M, Hoepken B, Irvin-Sellers O, VanLunen B, Bauer L, Rudwaleit M.
    RMD Open; 2020 Apr 03; 6(1):. PubMed ID: 32371433
    [Abstract] [Full Text] [Related]

  • 6. Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
    Ez-Zaitouni Z, Hilkens A, Gossec L, Berg IJ, Landewé R, Ramonda R, Dougados M, van der Heijde D, van Gaalen F.
    Arthritis Res Ther; 2017 May 31; 19(1):118. PubMed ID: 28569222
    [Abstract] [Full Text] [Related]

  • 7. Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.
    Lie E, Lindström U, Zverkova-Sandström T, Olsen IC, Forsblad-d'Elia H, Askling J, Kapetanovic MC, Kristensen LE, Jacobsson LTH.
    Ann Rheum Dis; 2017 Sep 31; 76(9):1515-1521. PubMed ID: 28254789
    [Abstract] [Full Text] [Related]

  • 8. The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study.
    Stolwijk C, Essers I, van Tubergen A, Boonen A, Bazelier MT, De Bruin ML, de Vries F.
    Ann Rheum Dis; 2015 Jul 31; 74(7):1373-8. PubMed ID: 24658834
    [Abstract] [Full Text] [Related]

  • 9. Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS.
    Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, Van den Bosch F, Dougados M, van Tubergen A.
    Rheumatology (Oxford); 2015 Apr 31; 54(4):633-40. PubMed ID: 25234663
    [Abstract] [Full Text] [Related]

  • 10. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
    Glintborg B, Sørensen IJ, Østergaard M, Dreyer L, Mohamoud AA, Krogh NS, Hendricks O, Andersen LS, Raun JL, Kowalski MR, Danielsen L, Pelck R, Nordin H, Pedersen JK, Kraus DG, Christensen SR, Hansen IM, Esbesen J, Schlemmer A, Loft AG, Al Chaer N, Salomonsen L, Hetland ML.
    J Rheumatol; 2017 Jan 31; 44(1):59-69. PubMed ID: 27909080
    [Abstract] [Full Text] [Related]

  • 11. Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.
    Ciurea A, Scherer A, Weber U, Exer P, Bernhard J, Tamborrini G, Riek M, Müller RB, Weiss B, Nissen MJ, Kissling R, Michel BA, Finckh A, Rheumatologists of Swiss Clinical Quality Management Program for Axial Spondyloarthritis.
    Ann Rheum Dis; 2016 Mar 31; 75(3):532-9. PubMed ID: 25667205
    [Abstract] [Full Text] [Related]

  • 12. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
    Mitulescu TC, Trandafir M, Dimăncescu MG, Ciuluvică RC, Popescu V, Predețeanu D, Istrate S, Voinea LM.
    Rom J Ophthalmol; 2018 Mar 31; 62(2):114-122. PubMed ID: 30206554
    [Abstract] [Full Text] [Related]

  • 13. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X, Wendling D, Botteman MF, Carter JA, Rao S, Cifaldi M.
    J Med Econ; 2012 Mar 31; 15(6):1054-63. PubMed ID: 22563743
    [Abstract] [Full Text] [Related]

  • 14. Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?
    Lindström U, Bengtsson K, Olofsson T, Di Giuseppe D, Glintborg B, Forsblad-d'Elia H, Jacobsson LTH, Askling J.
    Ann Rheum Dis; 2021 Nov 31; 80(11):1445-1452. PubMed ID: 34130984
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
    Webers C, Ortolan A, Sepriano A, Falzon L, Baraliakos X, Landewé RBM, Ramiro S, van der Heijde D, Nikiphorou E.
    Ann Rheum Dis; 2023 Jan 31; 82(1):130-141. PubMed ID: 36270657
    [Abstract] [Full Text] [Related]

  • 16. HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry.
    Fröhlich F, Micheroli R, Hebeisen M, Kissling S, Bürki K, Exer P, Bräm R, Niedermann K, Möller B, Nissen MJ, Kyburz D, Andor M, Distler O, Scherer A, Ciurea A.
    Clin Rheumatol; 2023 May 31; 42(5):1267-1274. PubMed ID: 36574181
    [Abstract] [Full Text] [Related]

  • 17. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.
    Clin Exp Rheumatol; 2019 May 31; 37(5):762-767. PubMed ID: 31025925
    [Abstract] [Full Text] [Related]

  • 18. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
    Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, Feltelius N, Hetland ML, Askling J, ARTIS Study Group, For the DANBIO Study Group.
    Ann Rheum Dis; 2017 Jan 31; 76(1):105-111. PubMed ID: 27147709
    [Abstract] [Full Text] [Related]

  • 19. Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS.
    Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A.
    Clin Exp Rheumatol; 2016 Jan 31; 34(2):214-21. PubMed ID: 26843505
    [Abstract] [Full Text] [Related]

  • 20. Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.
    Yahya F, Gaffney K, Hamilton L, Lonsdale E, Leeder J, Brooksby A, Cavill C, Berry-Jenkins J, Boyle C, Bond D, Sengupta R, for BRITSpA.
    Rheumatology (Oxford); 2018 Apr 01; 57(4):619-624. PubMed ID: 29272541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.